Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance). Read more about Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance).
Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice. Read more about Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice.
A scoping review of the nurse practitioner workforce in oncology. Read more about A scoping review of the nurse practitioner workforce in oncology.
History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC). Read more about History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC).
A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma. Read more about A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma.
High-risk older smokers' perceptions, attitudes, and beliefs about lung cancer screening. Read more about High-risk older smokers' perceptions, attitudes, and beliefs about lung cancer screening.
Smoking and mortality after breast cancer diagnosis: the health and functioning in women study. Read more about Smoking and mortality after breast cancer diagnosis: the health and functioning in women study.
Environmental scan of anal cancer screening practices: worldwide survey results. Read more about Environmental scan of anal cancer screening practices: worldwide survey results.
Intestinal tumor suppression in ApcMin/+ mice by prostaglandin D2 receptor PTGDR. Read more about Intestinal tumor suppression in ApcMin/+ mice by prostaglandin D2 receptor PTGDR.
Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657). Read more about Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657).